Senior Technology Program Leader, Translational Medicine -Biomarkers
Genentech · South San Francisco, CA · Research & Development
About this role
Genentech is hiring a senior-level Program Manager in the operations function based in South San Francisco, CA. The posting calls out experience with Performance Optimization, Data Analytics. Compensation is listed at $142,000–$264,200 per year.
- Role
- Program Manager
- Function
- operations
- Level
- senior
- Track
- Individual contributor
- Employment
- Full-time
- Location
- South San Francisco, CA
- Department
- Research & Development
- Posted
- Apr 15, 2026
More roles at Genentech
Job description
from Genentech careersThe Position
A healthier future. It’s what drives us to innovate. To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come. Creating a world where we all have more time with the people we love. That’s what makes us Genentech.
This role is based in the Technology Innovation Enablement (TIE) team, a strategic search and evaluation unit within the Scientific Operations, Diagnostic and Technology (ODT) group of gRED Translational Medicine. TIE’s mission is to identify emerging biomarker testing solutions and build partnerships required to critically evaluate, develop and implement them. We serve as a catalyst for translational innovation, aligning cross-functional resources behind the ‘big bets’ that anticipate future testing paradigms and that deliver long term value to our research and development goals.
The Position
As a Biomarker Technology Program Manager, you will leverage a technical and product management approach to drive translational innovation. Your core responsibility is to collaborate with cross-functional partners to co-develop strategies and execute projects that evaluate and deploy fit-for-purpose biomarker testing innovations into our translational research programs. This role directly impacts drug development by delivering a portfolio of operationalized biomarker testing solutions (e.g. novel assays, analytic models, platforms, and central lab services) that facilitate more accurate clinical development decision-making and accelerate the delivery of transformative medicines to patients.